Search Login Register

Muscular Atrophy (Muscle Atrophy) Summary

Description: Derangement in size and number of muscle fibers occurring with aging, reduction in blood supply, or following immobilization, prolonged weightlessness, malnutrition, and particularly in denervation.

Also Known As: Muscle Atrophy; Atrophy, Muscle; Neurotrophic Muscular Atrophy; Atrophies, Muscle; Atrophies, Muscular Show All >>

Networked: 1938 relevant articles (63 outcomes, 210 trials/studies) for this Disease

Key Drugs and Agents for Muscular Atrophy

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Ubiquitin : 5 outcomes 21 studies in 180 results : IBA
  2. Insulin-Like Growth Factor I (IGF-1) : 3 outcomes 8 studies in 67 results : IBA
  3. Proteins (Proteins, Gene) : 3 outcomes 7 studies in 66 results : IBA
  4. Testosterone (Sustanon) : 3 outcomes 4 studies in 27 results : FDA 13
  5. Ligases : 2 outcomes 8 studies in 83 results : IBA
  6. Dexamethasone (Maxidex) : 2 outcomes 8 studies in 48 results : FDA 77 Generic
  7. Clenbuterol : 2 outcomes 3 studies in 16 results : IBA
  8. superoxide dismutase 1 : 2 outcomes 1 study in 3 results : IBA
  9. DNA (Deoxyribonucleic Acid) : 2 outcomes in 15 results : IBA
  10. Vitamin E : 2 outcomes in 8 results : FDA 13 Generic
Show All >>

Diseases Related to Muscular Atrophy

  1. Hypertrophy
  2. Atrophy
  3. Inflammation
  4. Cachexia
  5. Paralysis (Palsy)
Show All >>

Key Therapies for Muscular Atrophy

Efficacy Chart >>
  1. Denervation : 6 outcomes 24 studies in 199 results
  2. Resistance Training : 2 outcomes 5 studies in 19 results
  3. Tenotomy : 2 outcomes 1 study in 16 results
  4. Injections : 2 outcomes 1 study in 16 results
  5. Oral Administration : 2 outcomes 1 study in 6 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.